1. Home
  2. BDSX vs AIRS Comparison

BDSX vs AIRS Comparison

Compare BDSX & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • AIRS
  • Stock Information
  • Founded
  • BDSX 2005
  • AIRS 2012
  • Country
  • BDSX United States
  • AIRS United States
  • Employees
  • BDSX N/A
  • AIRS N/A
  • Industry
  • BDSX Precision Instruments
  • AIRS Medical/Nursing Services
  • Sector
  • BDSX Health Care
  • AIRS Health Care
  • Exchange
  • BDSX Nasdaq
  • AIRS Nasdaq
  • Market Cap
  • BDSX 194.9M
  • AIRS 400.5M
  • IPO Year
  • BDSX 2020
  • AIRS 2021
  • Fundamental
  • Price
  • BDSX $1.51
  • AIRS $5.35
  • Analyst Decision
  • BDSX Strong Buy
  • AIRS Hold
  • Analyst Count
  • BDSX 4
  • AIRS 2
  • Target Price
  • BDSX $3.08
  • AIRS $5.00
  • AVG Volume (30 Days)
  • BDSX 332.5K
  • AIRS 248.7K
  • Earning Date
  • BDSX 11-01-2024
  • AIRS 11-08-2024
  • Dividend Yield
  • BDSX N/A
  • AIRS N/A
  • EPS Growth
  • BDSX N/A
  • AIRS N/A
  • EPS
  • BDSX N/A
  • AIRS N/A
  • Revenue
  • BDSX $65,562,000.00
  • AIRS $188,780,000.00
  • Revenue This Year
  • BDSX $46.97
  • AIRS N/A
  • Revenue Next Year
  • BDSX $30.43
  • AIRS $10.31
  • P/E Ratio
  • BDSX N/A
  • AIRS N/A
  • Revenue Growth
  • BDSX 48.92
  • AIRS N/A
  • 52 Week Low
  • BDSX $1.11
  • AIRS $2.92
  • 52 Week High
  • BDSX $2.21
  • AIRS $9.20
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 48.94
  • AIRS 38.88
  • Support Level
  • BDSX $1.24
  • AIRS $5.58
  • Resistance Level
  • BDSX $1.43
  • AIRS $6.60
  • Average True Range (ATR)
  • BDSX 0.10
  • AIRS 0.58
  • MACD
  • BDSX 0.01
  • AIRS -0.15
  • Stochastic Oscillator
  • BDSX 64.44
  • AIRS 0.43

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

Share on Social Networks: